Neurogenic bowel and continence programs for the individual with spina bifida

Susan Leibold1

  • 1Clinical Nurse Specialist - Pediatrics, Texas Scottish Rite Hospital for Children, Developmental Disabilities, 2222 Welborn Street, Dallas, TX 75219, USA. Tel.: +1 214 559 7860; Fax: +1 214 559 7835;

Insights

Managing neurogenic bowel in spina bifida requires a structured approach. Key strategies involve timed medications, regular toileting, and an interdisciplinary team for lifelong continence management.

Area of Science:

  • Neuroscience
  • Pediatric Gastroenterology
  • Urology

Background:

  • Neurogenic bowel in spina bifida presents unique challenges due to its developmental origins, differing from spinal cord injury-related neurogenic bowel.
  • Limited research exists on the efficacy of continence programs for individuals with spina bifida.

Purpose of the Study:

  • To outline a comprehensive management framework for neurogenic bowel in spina bifida.
  • To highlight the importance of tailored continence programs for achieving bowel regularity and independence.

Main Methods:

  • Utilizing a thirteen-item assessment framework including stool form, physiology, family history, diet, and medications.
  • Implementing developmentally appropriate programs to encourage child participation.
  • Employing timed medication and evacuation strategies, including oral medications, suppositories, or enemas.

Main Results:

  • Successful management relies on precise timing of medications and bowel evacuation.
  • An interdisciplinary team approach is crucial for sustained support.
  • Dietary modifications and adaptive techniques are vital components.

Conclusions:

  • Effective neurogenic bowel management in spina bifida necessitates a multifaceted, individualized approach.
  • Early intervention and consistent application of continence strategies promote long-term independence.
  • Collaboration between healthcare professionals, particularly dietitians and occupational therapists, optimizes outcomes.

Related Concept Videos

Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Spinal Cord Injury ll: Pathophysiology01:14

Spinal Cord Injury ll: Pathophysiology

Spinal cord injury progresses through two interconnected phases: primary injury and secondary injury.Primary InjuryPrimary injury happens at the moment of trauma and involves immediate mechanical damage to the spinal cord.Compression happens when broken vertebrae, herniated discs, or accumulating blood (such as a hematoma) press directly against the spinal cord, distorting its normal shape and function. In cases of contusion, the cord is bruised by a blunt force (like penetrating injuries or...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...